Systemic delivery of therapeutic peptides and proteins
暂无分享,去创建一个
[1] L. John,et al. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin , 1988 .
[2] Yie W. Chien,et al. Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications , 1988 .
[3] B. Tarquini,et al. Prominent circadian absorption of intranasal salmon calcitonin (SCT) in healthy subjects. , 1988, Chronobiology international.
[4] D. Neckers,et al. Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs. , 1988, Journal of pharmaceutical sciences.
[5] E. Shefter,et al. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. , 1988, The Journal of pharmacology and experimental therapeutics.
[6] W. Shi,et al. Transdermal Iontophoretic Delivery of Therapeutic Peptides/Proteins I: Insulin , 1987, Annals of the New York Academy of Sciences.
[7] Nishihata Toshiaki,et al. An effective formulation for an insulin suppository; examination in normal dogs , 1987 .
[8] Toshio Itoh. Biotech Trends in the Japanese Pharmaceutical Industry , 1987, Bio/Technology.
[9] J. McElnay,et al. Binding of human insulin to burette administration sets , 1987 .
[10] J. Flier,et al. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. , 1987, Journal of pharmaceutical sciences.
[11] Y. Chien,et al. Facilitated transdermal transport of insulin. , 1987, Journal of pharmaceutical sciences.
[12] P. S. Adams,et al. Stability of insulin mixtures in disposable plastic insulin syringes , 1987, The Journal of pharmacy and pharmacology.
[13] G. Menon,et al. High-Performance Liquid Chromatographic Assay for Thyrotropin Releasing Hormone and Benzyl Alcohol in Injectable Formulation , 1987, Pharmaceutical Research.
[14] J. Robinson,et al. Controlled Drug Delivery : Fundamentals and Applications, Second Edition , 1987 .
[15] Vincent Li. Influence of Drug Properties and Routes of Drug Administration on the Design of Sustained and Controlled Release Systems , 1987 .
[16] R. Baum. California Biotechnology Pursues Alternative Product Strategy: A latecomer to the biotech scene, firm focuses on human pharmaceuticals for medical markets not being addressed by other biotech companies , 1987 .
[17] J. Adamson,et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.
[18] C. Rhodes,et al. Scientific and Regulatory Aspects of Macromolecular Drugs and Devices , 1987 .
[19] Y. Chien,et al. Intranasal drug delivery for systemic medications. , 1987, Critical reviews in therapeutic drug carrier systems.
[20] Nishihata Toshiaki,et al. Trials of rectal insulin suppositories in healthy humans , 1986 .
[21] G. Boer,et al. The use of [3H]vasopressin for in‐vivo studies of controlled delivery from an Accurel/collodion device in the Brattleboro rat , 1986, The Journal of pharmacy and pharmacology.
[22] M. Sakon,et al. Studies on liposome-encapsulated heparin. , 1986, Thrombosis research.
[23] D. Neckers,et al. A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.
[24] M. S. McCracken,et al. Determination of total and encapsulated insulin in a vesicle formulation. , 1986, Journal of pharmaceutical sciences.
[25] B. Salbu,et al. Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insulin from an infusion system. , 1986, American journal of hospital pharmacy.
[26] R. Burnette,et al. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. , 1986, Journal of pharmaceutical sciences.
[27] V. H. Lee,et al. Hydrolysis of enkephalins in homogenates of anterior segment tissues of the albino rabbit eye. , 1986, Investigative ophthalmology & visual science.
[28] M. Dibner. Biotechnology in Europe , 1986, Science.
[29] V. H. Lee,et al. Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases. , 1986, Life sciences.
[30] E. Touitou,et al. Targeted enteral delivery of insulin to rats , 1986 .
[31] G. Liversidge,et al. Effect of suppository shape on the systemic availability of rectally administered insulin and sodium salicylate , 1986 .
[32] Controlled Release of Insulin From Polymer Matrices: In Vitro Kinetics , 1986, Diabetes.
[33] E. Edelman,et al. Controlled Release of Insulin From Polymer Matrices: Control of Diabetes in Rats , 1986, Diabetes.
[34] T. Nagai,et al. Topical mucosal adhesive dosage forms , 1986, Medicinal research reviews.
[35] V. H. Lee,et al. Macromolecular drug absorption in the albino rabbit eye , 1986 .
[36] L. King,et al. Role of epidermal growth factor in carcinogenesis. , 1986, Cancer research.
[37] B. Kári. Control of Blood Glucose Levels in Alloxan-diabetic Rabbits by Iontophoresis of Insulin , 1986, Diabetes.
[38] P. S. Adams,et al. Analysis of bovine, procine and human insulins in pharmaceutical dosage forms and drug delivery systems , 1986 .
[39] M. Humphrey. The Oral Bioavailability of Peptides and Related Drugs , 1986 .
[40] Swann Jp. Insulin: a case study in the emergence of collaborative pharmacomedical research. , 1986 .
[41] S. Atlas. Atrial natriuretic factor: a new hormone of cardiac origin. , 1986, Recent progress in hormone research.
[42] M. Durán,et al. Analysis of solvent-mediated conformational changes of insulin by radioimmunoassay (RIA) techniques. , 1986, Journal of pharmaceutical and biomedical analysis.
[43] D. Baxter. A radioreceptor assay for pharmaceutical preparations of insulin. , 1986, Journal of biological standardization.
[44] D. Smith,et al. HPLC as a replacement for the animal response assays for insulin. , 1986, Journal of pharmaceutical and biomedical analysis.
[45] C. Stoscheck,et al. Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins , 1986, Journal of cellular biochemistry.
[46] R. Stratford,et al. Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. , 1986, Journal of ocular pharmacology.
[47] T. Nagai. Adhesive topical drug delivery system , 1985 .
[48] Buddy D. Ratner,et al. Glucose sensitive membranes for controlled delivery of insulin: Insulin transport studies , 1985 .
[49] G. S. Gordon,et al. Nasal absorption of insulin: enhancement by hydrophobic bile salts. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Robinson,et al. Ocular delivery of progesterone using a bioadhesive polymer , 1985 .
[51] K. Morimoto,et al. Effect of non‐ionic surfactants in a polyacrylic acid gel base on the rectal absorption of [Asu1,7]‐eel calcitonin in rats , 1985, The Journal of pharmacy and pharmacology.
[52] R. Lenk,et al. Liposome-collagen gel matrix: a novel sustained drug delivery system. , 1985, Journal of pharmaceutical sciences.
[53] L. R. Reynolds,et al. Long-term follow-up of diabetic patients using insulin infusion pumps. Considerations for future clinical application. , 1985, Archives of internal medicine.
[54] V. H. Lee,et al. Aminopeptidase activity in albino rabbit extraocular tissues relative to the small intestine. , 1985, Journal of pharmaceutical sciences.
[55] E. Edelman,et al. Controlled Release and Magnetically Modulated Systems for Macromolecular Drugs , 1985, Annals of the New York Academy of Sciences.
[56] R. Shownkeen,et al. Studies of the heterogeneity of human pituitary LH by fast protein liquid chromatography. , 1985, The Journal of endocrinology.
[57] S. Sarnoff,et al. Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[58] A. Hoffman,et al. Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its Analogs , 1985 .
[59] J. Hardy,et al. Intranasal drug delivery by spray and drops , 1985, The Journal of pharmacy and pharmacology.
[60] R. Eaton,et al. Insulin delivery: how, when, and where. , 1985, The New England journal of medicine.
[61] J. Manson,et al. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. , 1985 .
[62] L G Mendelsohn,et al. Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats. , 1985, Journal of pharmaceutical sciences.
[63] V. H. Lee,et al. Ocular drug bioavailability from topically applied liposomes. , 1985, Survey of ophthalmology.
[64] B. Koch,et al. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors. , 1985, Endocrinology.
[65] K Morimoto,et al. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel , 1985, The Journal of pharmacy and pharmacology.
[66] R. Kawamori,et al. Enhanced bioavailability of insulin after rectal administration with enamine as adjuvant in depancreatized dogs , 1985, The Journal of pharmacy and pharmacology.
[67] John C. Petricciani,et al. REGULATORY CONSIDERATIONS FOR PRODUCTS DERIVED FROM THE NEW BIOTECHNOLOGY , 1985 .
[68] G. Liversidge,et al. Effect of rectal suppository formulation on the release of insulin and on the glucose plasma levels in dogs , 1985 .
[69] Elander Richard Paul. Biotechnology: Present and Future Roles in the Pharmaceutical Industry , 1985 .
[70] Wood Jf. Liposomes for oral administration of drugs. , 1985 .
[71] V. H. Lee,et al. Ocular aminopeptidase activity and distribution in the albino rabbit. , 1985, Current eye research.
[72] D. Wise,et al. Medical Applications of Controlled Release , 2019 .
[73] G. Boer,et al. Controlled long-term release of small peptide hormones using a new microporous polypropylene polymer: its application for vasopressin in the Brattleboro rat and potential perinatal use. , 1984, Journal of pharmaceutical sciences.
[74] M. Poznansky,et al. Biological approaches to the controlled delivery of drugs: a critical review. , 1984, Pharmacological reviews.
[75] H. Tokunaga,et al. Analysis of insulins by high-performance liquid chromatography. III. Determination of insulin in various preparations. , 1984, Chemical & pharmaceutical bulletin.
[76] K. Morimoto,et al. Enhanced rectal absorption of [Asu1,7]-eel calcitonin in rats using polyacrylic acid aqueous gel base. , 1984, Journal of pharmaceutical sciences.
[77] J. Feijen,et al. Self-regulating insulin delivery systems I. Synthesis and characterization of glycosylated insulin , 1984 .
[78] D. Lewis,et al. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. , 1984, Journal of pharmaceutical sciences.
[79] W A Check. New drugs and drug-delivery systems in the year 2000. , 1984, American journal of hospital pharmacy.
[80] R. Langer,et al. Sintering technique for the preparation of polymer matrices for the controlled release of macromolecules. , 1984, Journal of pharmaceutical sciences.
[81] K. Cantell,et al. Differential expression of human interferon genes. , 1984, Nucleic acids research.
[82] R. E. Jones,et al. Nasal absorption of nafarelin acetate, the decapeptide [D-Nal(2)6)]LHRH, in rhesus monkeys. I. , 1984, Journal of pharmaceutical sciences.
[83] D. Gibson,et al. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection , 1984, Clinical pharmacology and therapeutics.
[84] F. Van de Werf,et al. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. , 1984, The New England journal of medicine.
[85] S. Teutsch,et al. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. , 1984, The New England journal of medicine.
[86] E. Ziv,et al. Rectal administration of insulin. , 1984, Israel journal of medical sciences.
[87] T. Tice,et al. Microencapsulation of the peptide nafarelin acetate for controlled release. , 1984 .
[88] R. Langer,et al. Sintered Polymers for Sustained Macromolecular Drug Release , 1984 .
[89] D. G. Allen,et al. Insulin Delivery at Variable Rates from a Controlled Release Micropump , 1984 .
[90] G. Schuster,et al. Protein chemistry as related to cosmetics and toiletries , 1984 .
[91] J. Feijen,et al. Self Regulating Insulin Delivery System — A Chemical Approach , 1984 .
[92] G. Mcrae,et al. In vivo assessment of long-acting formulations of luteinizing hormone-releasing hormone analogs. , 1984 .
[93] J. Kost,et al. A Bioresponsive Membrane for Insulin Delivery , 1984 .
[94] S. Jacobsen,et al. Potential novel methods for insulin administration: I. Iontophoresis. , 1984, Biomedica biochimica acta.
[95] R. Bradshaw,et al. Polypeptide growth factors. , 1984, Annual review of biochemistry.
[96] J. Andrade,et al. Minimizing the aggregation of neutral insulin solutions. , 1983, Journal of pharmaceutical sciences.
[97] J. Flier,et al. Insulin Administered Intranasally as an Insulin-Bile Salt Aerosol: Effectiveness and Reproducibility in Normal and Diabetic Subjects , 1983, Diabetes.
[98] F. Hayden,et al. Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2. , 1983, The Journal of infectious diseases.
[99] M. Vance,et al. Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men. , 1983, The Journal of clinical endocrinology and metabolism.
[100] S. Anik,et al. Adsorption of d-Nal(2) 6LHRH, a decapeptide, onto glass and other surfaces , 1983 .
[101] G. Liversidge,et al. Effect of aprotinin on the rectal delivery of insulin , 1983, The Journal of pharmacy and pharmacology.
[102] J. Meek. Derivatizing reagents for high-performance liquid chromatography detection of peptides at the picomole level , 1983 .
[103] S. Pestka. The Purification and Manufacture of Human Interferons , 1983 .
[104] G. Boer,et al. Long-term and constant release of vasopressin from Accurel tubing: implantation in the Brattleboro rat. , 1983, The Journal of endocrinology.
[105] E. Touitou,et al. Promoted rectal absorption of insulin: formulative parameters involved in the absorption from hydrophilic bases , 1983 .
[106] J. Chow,et al. Physical Stability of Insulin Formulations , 1983, Diabetes.
[107] Morimoto Kazuhiro,et al. Enhancement of rectal absorption of insulin in polyacrylic acid aqueous gel bases containing long chain fatty acid in rats , 1983 .
[108] J Bird,et al. The encapsulation of insulin in erythrocytes , 1983, The Journal of pharmacy and pharmacology.
[109] K. Nolph,et al. Nature of insulin binding to plastic bags. , 1983, American journal of hospital pharmacy.
[110] Y. Yamasaki,et al. Insulin suppository: enhanced rectal absorption of insulin using an enamine derivative as a new promoter , 1983, The Journal of pharmacy and pharmacology.
[111] N. Yata,et al. Adjuvant effects of glyceryl esters of acetoacetic acid on rectal absorption of insulin and inulin in rabbits. , 1983, Journal of pharmaceutical sciences.
[112] S. W. Kim,et al. Prevention of insulin self-association and surface adsorption. , 1983, Journal of pharmaceutical sciences.
[113] T. Higuchi,et al. Enhancement of rectal absorption of insulin using salicylates in dogs , 1983, The Journal of pharmacy and pharmacology.
[114] I. S. Johnson. Human insulin from recombinant DNA technology. , 1983, Science.
[115] T. Higuchi,et al. Effect of enamine derivatives on the rectal absorption of insulin in dogs and rabbits , 1983, The Journal of pharmacy and pharmacology.
[116] D. Regoli,et al. Pharmacology of bradykinin and related kinins. , 1980, Advances in experimental medicine and biology.
[117] Emil L. Smith. Principles of Biochemistry: General Aspects , 1983 .
[118] A. Kitabchi,et al. The use of continuous insulin delivery systems in treatment of diabetes mellitus. , 1983, Advances in internal medicine.
[119] E. Berry,et al. The absorption of insulin from various regions of the rat intestine. , 1982, Life sciences.
[120] A. Hoffman,et al. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. , 1982, The New England journal of medicine.
[121] E L Korwek. FDA, OSHA, and EPA regulation of the recombinant DNA technology. , 1982, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[122] L. Wide,et al. Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism. , 1982, The Journal of clinical endocrinology and metabolism.
[123] M. Sinha,et al. Orally administered liposome-entrapped insulin in diabetic animals. A critical assessment. , 1982, Hormone research.
[124] M. Ueno,et al. Oral administration of liposomally-entrapped heparin to beagle dogs. , 1982, Chemical & pharmaceutical bulletin.
[125] K. Cantell,et al. Purified interferon as protection against rhinovirus infection. , 1982, British medical journal.
[126] J. Parsons,et al. Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs. , 1982, Biochimica et biophysica acta.
[127] T. Higuchi,et al. Enhanced rectal bioavailability of polypeptides using sodium 5-methoxysalicylate as an absorption promoter. , 1982, Journal of pharmaceutical sciences.
[128] W. Miller. Insulins, Growth Hormone, and Recombinant DNA Technology , 1982 .
[129] R. Good. Introductory comments , 1982, Journal of Clinical Immunology.
[130] D. Nathan. successful Treatment of Extremely Brittle, Insulin-dependent Diabetes with a Novel Subcutaneous Insulin Pump Regimen , 1982, Diabetes Care.
[131] A. Secchi,et al. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. , 1982, British medical journal.
[132] Lewis Dh,et al. Biodegradable microcapsules for contraceptive steroids. , 1982 .
[133] G. Godeau,et al. Pharmacological studies on elastin peptides (kappa-elastin). Blood clearance, percutaneous penetration and tissue distribution. , 1981, Pathologie-biologie.
[134] T. Higuchi,et al. Enhanced rectal absorption of insulin and heparin in rats in the presence of non‐surfactant adjuvants , 1981, The Journal of pharmacy and pharmacology.
[135] B. V. Fisher,et al. Stability of bovine insulin , 1981, The Journal of pharmacy and pharmacology.
[136] E. Berry,et al. Bile salts promote the absorption of insulin from the rat colon. , 1981, Life sciences.
[137] Y. Takatsuka,et al. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants , 1981 .
[138] D. Lewis,et al. Clinical evaluation of injectable biodegradable contraceptive system. , 1981, American journal of obstetrics and gynecology.
[139] Y. Yamasaki,et al. The Effectiveness of Rectal Administration of Insulin Suppository on Normal and Diabetic Subjects , 1981, Diabetes Care.
[140] N. Yata,et al. Study of enamine derivatives of phenylglycine as adjuvants for the rectal absorption of insulin. , 1981, Chemical & pharmaceutical bulletin.
[141] G. Durand,et al. Oral ingestion of insulin liposomes: effects of the administration route. , 1981, Life sciences.
[142] J. Kawada,et al. No reduction of blood glucose in diabetic rats after oral administration of insulin liposomes prepared under acidic conditions. , 1981, Endocrinologia japonica.
[143] T. Nagai,et al. New mucosal dosage form of insulin. , 1981, Chemical & pharmaceutical bulletin.
[144] J. A. Hoffmann,et al. Chemical, Physical, and Biologic Properties of Biosynthetic Human Insulin , 1981, Diabetes Care.
[145] J. Bringer,et al. Prevention of Insulin Aggregation by Dicarboxylic Amino Acids During Prolonged Infusion , 1981, Diabetes.
[146] M. Mesiha,et al. Biopharmaceutical study of insulin suppositories. , 1981, Die Pharmazie.
[147] J. Sciarra,et al. LHRH peptides as female and male contraceptives. , 1981 .
[148] E. Touitou,et al. Effective intestinal absorption of insulin in diabetic rats using a new formulation approach , 1980, The Journal of pharmacy and pharmacology.
[149] H. Maeno,et al. Rectal absorption of insulin suppositories in rabbits , 1980, The Journal of pharmacy and pharmacology.
[150] D. Breimer,et al. Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination. , 1980, Journal of pharmaceutical sciences.
[151] W. Crowley,et al. Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). , 1980, The Journal of clinical endocrinology and metabolism.
[152] R. Langer,et al. Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. , 1980, Journal of pharmaceutical sciences.
[153] T. Mizutani. Decreased activity of proteins adsorbed onto glass surfaces with porous glass as a reference. , 1980, Journal of pharmaceutical sciences.
[154] G. Durand,et al. HYPOGLYCEMIA AFTER LIPOSOMIZED INSULIN IN THE RAT: 55 , 1980, Pediatric Research.
[155] H. Bucher,et al. EFFECT OF INTRANASAL LHRH THERAPY ON PLASMA LH, FSH AND TESTOSTERONE, AND RELATION TO CLINICAL RESULTS IN PREPUBERTAL BOYS WITH CRYPTORCHIDISM , 1980, Clinical endocrinology.
[156] S. W. Kim,et al. CONTROLLED RELEASE OF ANTITHROMBOTIC AGENTS FROM POLYMER MATRICES , 1980 .
[157] K. Morimoto,et al. Pharmaceutical studies of polyacrylic acid aqueous gel bases: absorption of insulin from polyacrylic acid aqueous gel bases following rectal administration in alloxan diabetic rats and rabbits. , 1980, Journal of pharmacobio-dynamics.
[158] W. Tamborlane,et al. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.
[159] P. Privalov. Stability of proteins: small globular proteins. , 1979, Advances in protein chemistry.
[160] T. Plant,et al. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone , 1978 .
[161] M. Donbrow,et al. New hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin , 1978, The Journal of pharmacy and pharmacology.
[162] T. Mizutani,et al. Estimation of adsorption of drugs and proteins on glass surfaces with controlled pore glass as a reference. , 1978, Journal of pharmaceutical sciences.
[163] S. Hirai,et al. Nasal Absorption of Insulin in Dogs , 1978, Diabetes.
[164] H Keen,et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.
[165] J. Wood,et al. Clinical signigicance of insulin adsorption by polyvinyl chloride infusion systems. , 1977, American journal of hospital pharmacy.
[166] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[167] B. Milthorpe,et al. Polymerization pattern of insulin at pH 7.0. , 1976, Biochemistry.
[168] A. Pert,et al. (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. , 1976, Science.
[169] J. Sciarra,et al. Development of an aerosol dosage form containing insulin. , 1976, Journal of pharmaceutical sciences.
[170] R. Kawamori,et al. Short-Term Treatment of Alloxan-Diabetic Rats with Intrajejunal Administration of Water-in-Oil-in-Water Insulin Emulsions , 1975, Diabetes.
[171] T. Mizutani,et al. Prevention of adsorption of protein on controlled-pore glass with amino acid buffer. , 1975, Journal of chromatography.
[172] J. Jonsen,et al. In vitro penetration of tritiated dextrans through rabbit oral mucosa. , 1975, Archives of oral biology.
[173] P. O’Farrell. High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.
[174] B. K. Davis. Diffusion of polymer gel implants. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[175] M Berman,et al. A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.
[176] C. Petty,et al. Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing. , 1974, Anesthesiology.
[177] R. Yalow. Radioimmunoassay methodology: application to problems of heterogeneity of peptide hormones. , 1973, Pharmacological reviews.
[178] G. Federici,et al. Insulin dissociation at alkaline pH , 1973, FEBS letters.
[179] T. Merigan,et al. Inhibition of respiratory virus infection by locally applied interferon. , 1973, Lancet.
[180] B. Frank,et al. Conformation of proinsulin. A comparison of insulin and proinsulin self-association at neutral pH. , 1972, Biochemistry.
[181] A. Vølund,et al. Stability of Insulin Preparations , 1972, Diabetes.
[182] R. Chez,et al. Use of Jet Insulin Injection in Diabetes Mellitus Therapy , 1972, Diabetes.
[183] J. Shipp,et al. Insulin Across Respiratory Mucosae by Aerosol Delivery , 1971, Diabetes.
[184] K. Tolo. A study of permeability of gingival pocket epithelium to albumin in guinea pigs and Norwegian pigs. , 1971, Archives of oral biology.
[185] C. Beardwell. Radioimmunoassay of arginine vasopressin in human plasma. , 1971, The Journal of clinical endocrinology and metabolism.
[186] L. Reichert,et al. Electrophoretic properties of pituitary gonadotropins as studied by electrofocusing. , 1971, Endocrinology.
[187] M. Ceska,et al. Solid-phase radioimmunoassay of insulin. , 1970, Acta endocrinologica.
[188] E. Haber,et al. A radioimmunoassay for bradykinin in plasma and synovial fluid. , 1969, The Journal of laboratory and clinical medicine.
[189] W. Mccrone,et al. Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.
[190] C. Crane,et al. Absorption of Insulin from the Human Small Intestine , 1968, Diabetes.
[191] W. O. Storvick,et al. Effect of Storage Temperature on Stability of Commercial Insulin Preparations , 1968, Diabetes.
[192] M. Dalmark. Plasma radioactivity after rectal instillation of radioiodine-labelled human albumin in normal subjects and in patients with ulcerative colitis. , 1968, Scandinavian journal of gastroenterology.
[193] A. Hartree. Separation and partial purification of the protein hormones from human pituitary glands. , 1966, The Biochemical journal.
[194] H. Klostermeyer,et al. The chemistry and biochemistry of insulin. , 1966, Angewandte Chemie.
[195] J. D. Whiffen,et al. The fate of the surface heparin of GBH-coated plastics after exposure to the blood stream. , 1966, The Journal of thoracic and cardiovascular surgery.
[196] C. Weller,et al. Jet injection of insulin vs the syringe-and-needle method. , 1966, JAMA.
[197] R. Tregear. The permeability of skin to albumin, dextrans and polyvinyl pyrrolidone. , 1966, The Journal of investigative dermatology.
[198] B. Davis. DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS * , 1964, Annals of the New York Academy of Sciences.
[199] J. Wieriks. RESORPTION OF ALPHA-AMYLASE UPON BUCCAL APPLICATION. , 1964, Archives internationales de pharmacodynamie et de therapie.
[200] A. Lazarow,et al. Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.
[201] N. R. Stephenson,et al. THERMAL STABILITY OF INSULIN MADE FROM ZINC INSULIN CRYSTALS , 1960, The Journal of pharmacy and pharmacology.
[202] J. B. Hill. Adsorption of Insulin to Glass.† ∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[203] J. Schlichtkrull,et al. Zinc insulin preparations for single daily injection; clinical studies of new preparations with prolonged action. , 1952, Journal of the American Medical Association.
[204] J. Hughes,et al. Clinical studies with jet injection; a new method of drug administration. , 1947, Current researches in anesthesia & analgesia.
[205] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .